This site contains promotional content intended for Healthcare Professionals in Ireland and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Recorded 2026

 |  
Session 3 & 4

ATTR-CM with Prof Marianna Fontana

Join us as Prof Fontana takes us through the clinical data, patient cases and other aspects related to ATTR-CM.
 

The

4 separate sessions
can be viewed below.

Prof. Marianna Fontana

Prof. Marianna Fontana photo250x260

Professor of Cardiology and Consultant Cardiologist at the Royal Free Hospital, University College London

Session 1

  • In this video Prof Fontana takes us through a patient case. She further explains the identification and diagnosis of ATTR-CM 

Duration time
| 15 minutes

Session 2

  • In this video Prof Fontana takes us through the standard of care and the evolving treatment landscape in ATTR-CM

Duration time
| 4 minutes

Session 3

  • In this video Prof Fontana highlights the pivotal ATTRibute CM clinical trial for Beyonttra (acoramidis).

Duration time
| 6 minutes

Session 4

  • In this video Prof Fontana explains the effects of Beyonttra (acoramidis) on biological and functional biomarkers as observed in the ATTRibute-CM clinical trial.

Duration time
| 6 minutes

 

PP-PF-CAR-IE-0015-1 | March 2026